Ziftomenib in relapsed or refractory acute myeloid leukaemia (KOMET-001): a multicentre, open-label, multi-cohort, phase 1 trial

Authors: Wang, Eunice S ^{*, *}, Issa, Ghayas C ^*, Erba, Harry P, Altman, Jessica K, Montesinos, Pau, DeBotton, Stephane, Walter, Roland B, Pettit, Kristen, Savona, Michael R, Shah, Mithun Vinod, Kremyanskaya, Marina, Baer, Maria R, Foran, James M, Schiller, Gary, Adès, Lionel, Heiblig, Mael, Berthon, Celine, Peterlin, Pierre, Rodríguez-Arbolí, Eduardo, Salamero, Olga, Patnaik, Mrinal M, Papayannidis, Cristina, Grembecka, Jolanta, Cierpicki, Tomasz, Clegg, Bradley, Ray, Joshua, Linhares, Brian M, Nie, Kun, Mitra, Amitava, Ahsan, Julie Mackey, Tabachri, Marilyn, Soifer, Harris S, Corum, Daniel, Leoni, Mollie, Dale, Stephen, Fathi, Amir T

Source: In The Lancet Oncology October 2024 25(10):1310-1324

Iadademstat in combination with azacitidine in patients with newly diagnosed acute myeloid leukaemia (ALICE): an open-label, phase 2a dose-finding study

Authors: Salamero, Olga ^*, Molero, Antonieta, Pérez-Simón, José Antonio, Arnan, Montserrat, Coll, Rosa, Garcia-Avila, Sara, Acuña-Cruz, Evelyn, Cano, Isabel, Somervaille, Tim C P, Gutierrez, Sonia, Arévalo, María Isabel, Xaus, Jordi, Buesa, Carlos, Limón, Ana, Faller, Douglas V, Bosch, Francesc, Montesinos, Pau

Source: In The Lancet Haematology July 2024 11(7):e487-e498

Clinical outcomes after CPX‐351 in patients with high‐risk acute myeloid leukemia: A comparison with a matched cohort from the Spanish PETHEMA registry

Authors: Bernal, Teresa, Moreno, Ainhoa Fernández, de LaIglesia, Almudena, Benavente, Celina, García‐Noblejas, Ana, Belmonte, Daniel García, Riaza, Rosalía, Salamero, Olga, Foncillas, Maria Angeles, Roldán, Alicia, Concepción, Víctor Noriega, González, Laura Llorente, Bergua Burgués, Juan Miguel, Lorente de Uña, Soraya, Rodríguez‐Macías, Gabriela, de la Fuente Burguera, Adolfo, García Pérez, Maria José, López‐Lorenzo, Jose Luis, Martínez, Pilar, Aláez, Concepción, Callejas, Marta, Martínez‐Chamorro, Carmen, Roca, José Rifón, Barciela, Lourdes Amador, Mena Durán, Armando V., Gómez Correcha, Karoll, Lavilla Rubira, Esperanza, Amigo, María Luz, Vall‐llovera, Ferran, Garrido, Ana, García‐Fortes, María, de Miguel Llorente, Dunia, Leonardo, Anastasia Aules, Cervero, Carlos, Jordá, Rosa Coll, Pérez‐Encinas, Manuel M., Zarzuela, Marta Polo, Figuera, Angela, Rad, Guillermo, Martínez‐Cuadrón, David, Montesinos, Pau

Source: Cancer medicine. 12(14):14892-14901

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100190078295.0x000001&indx=1&recIds=ETOCvdc_100190078295.0x000001

Transcriptional and genomic characterization of measurable residual disease in acute myeloid leukaemia

Authors: Simoes, Catia, Villar, Sara, Ariceta, Beñat, Garcés, Juan‐José, Burgos, Leire, Alignani, Diego, Sarvide, Sarai, Martínez‐Cuadrón, David, Bergua, Juan‐Miguel, Vives, Susana, Algarra, Lorenzo, Tormo, Mar, Martinez, Pilar, Serrano, Josefina, Herrera, Pilar, Ramos, Fernando, Salamero, Olga, Lavilla, Esperanza, Gil, Cristina, Lopez‐Lorenzo, Jose‐Luis, Vidriales, Maria‐Belen, Chillon, Carmen, Labrador, Jorge, Falantes, Jose‐Francisco, Sayas, María‐José, Ayala, Rosa, Martinez‐Lopez, Joaquin, Pierola, Ana Alfonso, Calasanz, Maria‐Jose, Prosper, Felipe, San‐Miguel, Jesús F., Sanz, Miguel Á., Paiva, Bruno, Montesinos, Pau

Source: British journal of haematology. 201(6):1239-1244

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100184650792.0x000001&indx=1&recIds=ETOCvdc_100184650792.0x000001

First‐in‐human study of JNJ‐63709178, a CD123/CD3 targeting antibody, in relapsed/refractory acute myeloid leukemia

Authors: Boyiadzis, Michael, Desai, Pinkal, Daskalakis, Nikki, Donnellan, William, Ferrante, Lucille, Goldberg, Jenna D., Grunwald, Michael R., Guttke, Christina, Li, Xiang, Perez‐Simon, Jose Antonio, Salamero, Olga, Tucker, Trevor, Xu, Xiaoying, Yang, Jay, Pemmaraju, Naveen, Alonso‐Dominguez, Juan Manuel

Source: Clinical and translational science. 16(3):429-435

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100179408291.0x000001&indx=1&recIds=ETOCvdc_100179408291.0x000001

Enasidenib vs conventional care in older patients with late-stage mutant-IDH2 relapsed/refractory AML: a randomized phase 3 trial

Authors: de Botton, Stéphane ^∗, Montesinos, Pau, Schuh, Andre C., Papayannidis, Cristina, Vyas, Paresh, Wei, Andrew H., Ommen, Hans, Semochkin, Sergey, Kim, Hee-Je, Larson, Richard A., Koprivnikar, Jaime, Frankfurt, Olga, Thol, Felicitas, Chromik, Jörg, Byrne, Jenny, Pigneux, Arnaud, Thomas, Xavier, Salamero, Olga, Vidriales, Maria Belen, Doronin, Vadim, Döhner, Hartmut, Fathi, Amir T., Laille, Eric, Yu, Xin, Hasan, Maroof, Martin-Regueira, Patricia, DiNardo, Courtney D.

Source: In Blood 12 January 2023 141(2):156-167

5′‐nucleotidase, cytosolic II genotype, and clinical outcome in patients with acute myeloid leukemia with intermediate‐risk cytogenetics

Authors: Díaz‐Santa, Johana, Rodríguez‐Romanos, Rocío, Coll, Rosa, Osca, Gemma, Pratcorona, Marta, González‐Bártulos, Marta, Garrido, Ana, Angona, Anna, Talarn, Carme, Tormo, Mar, Arnan, Montserrat, Vives, Susanna, Salamero, Olga, Tuset, Esperanza, Lloveras, Natàlia, Díez, Isabel, Zamora, Lurdes, Bargay, Joan, Sampol, Antonia, Cruz, David, Vila, Jordi, Sitges, Marta, Garcia, Antoni, Vall‐Llovera, Ferran, Esteve, Jordi, Sierra, Jorge, Gallardo, David

Source: European journal of haematology. 109(6):755-764

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100168269422.0x000001&indx=1&recIds=ETOCvdc_100168269422.0x000001

Prognostic impact of micromegakaryocytes in primary myelodysplastic syndromes

Authors: Saumell, Sílvia, Fernández-Serrano, Miranda, Mesa, Alba, López-Cadenas, Félix, Arenillas, Leonor, Alfonso, Ana, Montoro, Maria Julia, Molero, Antonieta, Leoz, Pilar, Riego, Victoria, Gallur, Laura, Salamero, Olga, Navarrete, Mayda, Tazón-Vega, Bárbara, Ortega, Margarita, Reig, Òscar, Roué, Gaël, Calvo, Xavier, Prosper, Felipe, Díez-Campelo, María, Valcárcel, David

Source: Leukemia & lymphoma. 63(5):1227-1235

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100154920197.0x000001&indx=1&recIds=ETOCvdc_100154920197.0x000001

Diverse real-life outcomes after intensive risk-adapted therapy for 1034 AML patients from the CETLAM Group.

Authors: Oñate, Guadalupe, Garrido, Ana, Arnan, Montserrat, Pomares, Helena, Alonso, Ester, Tormo, Mar, Diaz-Beya, Marina, Vives, Susana, Zamora, Lurdes, Sampol, Antonia, Coll, Rosa, Salamero, Olga, Cervera, Marta, Garcia, Antoni, Vall-Llovera, Ferran, Garcia-Avila, Sara, Bargay, Joan, Ortin, Xavier, Iranzo, Eva, Guijarro, Francisca

Source: Blood Cancer Journal; 1/11/2025, Vol. 15 Issue 1, p1-11, 11p

Subject Terms: ACUTE myeloid leukemia, YOUNG adults, OLDER people, SURVIVAL rate, KARYOTYPES

European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol

Authors: Bataller, Alex ^*, Garrido, Ana, Guijarro, Francesca, Oñate, Guadalupe, Diaz-Beyá, Marina, Arnan, Montserrat, Tormo, Mar, Vives, Susana, de Llano, María Paz Queipo, Coll, Rosa, Gallardo, David, Vall-Llovera, Ferran, Escoda, Lourdes, Garcia-Guiñon, Antonio, Salamero, Olga, Sampol, Antònia, Merchan, Brayan M., Bargay, Joan, Castaño-Díez, Sandra, Esteban, Daniel, Oliver-Caldés, Aina, Rivero, Andrea, Mozas, Pablo, López-Guerra, Mònica, Pratcorona, Marta, Zamora, Lurdes, Costa, Dolors, Rozman, Maria, Nomdedéu, Josep F., Colomer, Dolors, Brunet, Salut, Sierra, Jorge, Esteve, Jordi ^*

Source: In Blood Advances 22 February 2022 6(4):1193-1206

Prognostic impact of DNMT3A mutation in acute myeloid leukemia with mutated NPM1

Authors: Oñate, Guadalupe, Bataller, Alex, Garrido, Ana, Hoyos, Montserrat, Arnan, Montserrat, Vives, Susana, Coll, Rosa, Tormo, Mar, Sampol, Antònia, Escoda, Lourdes, Salamero, Olga, Garcia, Antoni, Bargay, Joan, Aljarilla, Alba, Nomdedeu, Josep F., Esteve, Jordi, Sierra, Jorge ^*, Pratcorona, Marta ^{*, *}

Source: In Blood Advances 8 February 2022 6(3):882-890

Measurable residual disease in elderly acute myeloid leukemia: results from the PETHEMA-FLUGAZA phase 3 clinical trial

Authors: Simoes, Catia ^*, Paiva, Bruno ^*, Martínez-Cuadrón, David, Bergua, Juan-Miguel, Vives, Susana, Algarra, Lorenzo, Tormo, Mar, Martinez, Pilar, Serrano, Josefina, Herrera, Pilar, Ramos, Fernando, Salamero, Olga, Lavilla, Esperanza, Gil, Cristina, Lopez, Jose-Luis, Vidriales, Maria-Belen, Labrador, Jorge, Falantes, Jose-Francisco, Sayas, María-José, Ayala, Rosa, Martinez-Lopez, Joaquin, Villar, Sara, Calasanz, Maria-Jose, Prosper, Felipe, San-Miguel, Jesús F., Sanz, Miguel Ángel, Montesinos, Pau

Source: In Blood Advances 9 February 2021 5(3):760-770

A phase 3 trial of azacitidine versus a semi‐intensive fludarabine and cytarabine schedule in older patients with untreated acute myeloid leukemia

Authors: Vives, Susana, Martínez‐Cuadrón, David, Bergua Burgues, Juan, Algarra, Lorenzo, Tormo, Mar, Martínez‐Sánchez, María Pilar, Serrano, Josefina, Herrera, Pilar, Ramos, Fernando, Salamero, Olga, Lavilla, Esperanza, López‐Lorenzo, José L., Gil, Cristina, Vidriales, Belén, Falantes, Jose F., Serrano, Alfons, Labrador, Jorge, Sayas, María J., Foncillas, María Á., Amador Barciela, María L., Olave, María Teresa, Colorado, Mercedes, Gascón, Adriana, Fernández, María Á., Simiele, Adriana, Pérez‐Encinas, Manuel M., Rodríguez‐Veiga, Rebeca, García, Olga, Martínez‐López, Joaquín, Barragán, Eva, Paiva, Bruno, Sanz, Miguel Á., Montesinos, Pau

Source: Cancer. 127(12):2003-2014

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100121101847.0x000001&indx=1&recIds=ETOCvdc_100121101847.0x000001

Ex vivo T‐cell depletion vs post‐transplant cyclophosphamide, sirolimus, and mycophenolate mofetil as graft‐vs‐host disease prophylaxis for allogeneic hematopoietic stem cell transplantation

Authors: Montoro, Juan, Roldán, Elisa, Piñana, José Luis, Barba, Pere, Chorão, Pedro, Quintero, Abdiel, Hernani, Rafael, Ortí, Guillermo, Lorenzo, José Ignacio, Balaguer‐Roselló, Aitana, Salamero, Olga, Fox, Laura, Solves, Pilar, Gómez, Inés, Guerreiro, Manuel, Hernández Boluda, Juan Carlos, Sanz, Guillermo, Solano, Carlos, Sanz, Miguel Ángel, Valcárcel, David, Sanz, Jaime

Source: European journal of haematology. 106(1):114-125

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100115230758.0x000001&indx=1&recIds=ETOCvdc_100115230758.0x000001

Feasibility of thiotepa addition to the fludarabine-busulfan conditioning with tacrolimus/sirolimus as graft vs host disease prophylaxis

Authors: Fox, María Laura, García-Cadenas, Irene, Pérez, Ariadna Martínez, Villacampa, Guillermo, Piñana, José Luis, Ortí, Guillermo, Montoro, Juan, Roldán, Elisa, Bosch Vilaseca, Anna, Martino, Rodrigo, Salamero, Olga, Saavedra, Silvana, Hernandez-Boluda, Juan Carlos, Esquirol, Albert, Sierra, Jordi, Sanz, Jaime, Solano, Carlos, Bosch, Francesc, Barba, Pere, Valcarcel, David

Source: Leukemia & lymphoma. 61(8):1823-1832

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100110727715.0x000001&indx=1&recIds=ETOCvdc_100110727715.0x000001

Acute myeloid leukemia with NPM1 mutation and favorable European LeukemiaNet category: outcome after preemptive intervention based on measurable residual disease

Authors: Bataller, Alex, Oñate, Guadalupe, Diaz‐Beyá, Marina, Guijarro, Francesca, Garrido, Ana, Vives, Susana, Tormo, Mar, Arnan, Montserrat, Salamero, Olga, Sampol, Antònia, Coll, Rosa, Vall‐Llovera, Ferran, Oliver‐Caldés, Aina, López‐Guerra, Mònica, Pratcorona, Marta, Zamora, Lurdes, Villamon, Eva, Roué, Gaël, Blanco, Adoración, Nomdedeu, Josep F., Colomer, Dolors, Brunet, Salut, Sierra, Jorge, Esteve, Jordi

Source: British journal of haematology. 191(1):52-61

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100110143714.0x000001&indx=1&recIds=ETOCvdc_100110143714.0x000001

Micronuclei, dmin chromosomes and MYC amplifications as a singular presentation of myeloid malignancies

Authors: Montoro, Maria Julia, Rivero, Eugenia, Teixidó, Montserrat, Rodriguez, Yva, Chávez, Carlos, Salamero, Olga, Navarrete, Mayda, Talavera, Elisabet, Ortega, Margarita, Valcárcel, David

Source: British journal of haematology. 191(1):e19-e22

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100110143753.0x000001&indx=1&recIds=ETOCvdc_100110143753.0x000001

Acute myeloid leukemia with inv(3)(q21.3q26.2)/t(3;3)(q21.3;q26.2): Study of 61 patients treated with intensive protocols

Authors: Sitges, Marta, Boluda, Blanca, Garrido, Ana, Morgades, Mireia, Granada, Isabel, Barragan, Eva, Arnan, Montserrat, Serrano, Josefina, Tormo, Mar, Miguel Bergua, Juan, Colorado, Mercedes, Salamero, Olga, Esteve, Jordi, Benavente, Celina, Pérez‐Encinas, Manuel, Coll, Rosa, Martí‐Tutusaus, Josep‐Maria, Brunet, Salut, Sierra, Jorge, Ángel Sanz, Miguel, Montesinos, Pau, Ribera, Josep‐Maria, Vives, Susana, Molero, Antonieta, Gallur, Laura, Gallur, Bárbara, Bataller, Alex, Díaz‐Beya, Marina, Gallardo, David, Vall‐llovera, Ferran, Martí‐Tutusaus, Josep Maria, Vidriales, María Belén, Riaza‐Grau, Rosalía, Legarda, Mario, Sayas, María Jose, Vera, Juan Antonio, Serrano, Alfons, Rodríguez, Carlos, Bargay, Joan, García, Daniel, Gil, Cristina, Martínez, María Pilar

Source: European journal of haematology. 105(2):138-147

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100107485922.0x000001&indx=1&recIds=ETOCvdc_100107485922.0x000001

Characteristics and outcome of adult patients with acute promyelocytic leukemia and increased body mass index treated with the PETHEMA Protocols

Authors: Sobas, Marta, Rodriguez‐Veiga, Rebeca, Vellenga, Edo, Paluszewska, Monika, De la Serna, Javier, García‐Álvarez, Flor, Gil, Cristina, Brunet, Salut, Bergua, Juan, González‐Campos, Jose, Ribera, José María, Tormo, Mar, González, Marcos, Fernández, Isolda, Benavente, Celina, González‐Sanmiguel, Jose D., Esteve, Jordi, Pérez‐Encinas, Manuel, Salamero, Olga, Manso, Felix, Lowenberg, Bob, Sanz, Miguel A., Montesinos, Pau

Source: European journal of haematology. 104(3):162-169

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100102912463.0x000001&indx=1&recIds=ETOCvdc_100102912463.0x000001

Analysis of relapse after transplantation in acute leukemia: A comparative on second allogeneic hematopoietic cell transplantation and donor lymphocyte infusions

Authors: Ortí, Guillermo ^*, Sanz, Jaime, García-Cadenas, Irene, Sánchez-Ortega, Isabel, Alonso, Laura, Jiménez, Maria José, Sisinni, Luisa, Azqueta, Carmen, Salamero, Olga, Badell, Isabel, Ferra, Christelle, de Heredia, Cristina Diaz, Parody, Rocio, Sanz, Miguel Angel, Sierra, Jorge, Piñana, Jose Luis, Querol, Sergi, Valcárcel, David

Source: In Experimental Hematology June 2018 62:24-32